Alkermes
ALKS
$24.45
Share price
0.04%
Change (1 day)
-19.86%
Change (1 year)
Categories
EPS for Alkermes (ALKS)
EPS in 2023 (TTM): $1.30
According to Alkermes's latest financial reports the company's current EPS (TTM) is $1.30. In 2022 the company made an earnings per share (EPS) of -$0.96 a decrease over its 2021 EPS that were of -$0.30.
EPS history for Alkermes from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $1.30 | -235.42% |
| 2022 | -$0.96 | 220% |
| 2021 | -$0.30 | -57.19% |
| 2020 | -$0.70 | -44.38% |
| 2019 | -$1.26 | 41.57% |
| 2018 | -$0.89 | -13.59% |
| 2017 | -$1.03 | -24.82% |
| 2016 | -$1.37 | -9.87% |
| 2015 | -$1.52 | 660% |
| 2014 | -$0.20 | -242.86% |
| 2013 | $0.14 | -137.84% |
| 2012 | -$0.37 | -39.34% |
| 2011 | -$0.61 | 24.49% |
| 2010 | -$0.49 | 19.51% |
| 2009 | -$0.41 | -130.37% |
| 2008 | $1.35 | -27.81% |
| 2007 | $1.87 | 1600% |
| 2006 | $0.11 | -164.71% |
| 2005 | -$0.17 | -81.91% |
| 2004 | -$0.94 | -40.88% |
| 2003 | -$1.59 | 8.9% |
| 2002 | -$1.46 | 75.9% |
| 2001 | -$0.83 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | 983.48% | 🇺🇸 USA |
 Novartis NVS | $3.74 | 187.69% | 🇨🇭 Switzerland |
 Pfizer PFE | $1.86 | 43.08% | 🇺🇸 USA |
 Sanofi SNY | $3.18 | 144.63% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $3.97 | 205.38% | 🇺🇸 USA |
 AstraZeneca AZN | $1.98 | 52.69% | 🇬🇧 UK |
 Acorda Therapeutics
ACOR | -$9.78 | -852.12% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | -$2.00 | -253.85% | 🇮🇱 Israel |